Kamala Harris: Going For The Banana Republican Nomination
By Mitch Berg
Alleged presidential candidate Kamala Harris on how she’ll solve the “crisis” in pharmaceutical prices:
Wait.
Wasn’t Trump supposed to be the wannabe dictator?
By Mitch Berg
Alleged presidential candidate Kamala Harris on how she’ll solve the “crisis” in pharmaceutical prices:
Wait.
Wasn’t Trump supposed to be the wannabe dictator?
This entry was posted by by Mitch Berg on Tuesday, November 26th, 2019 at 6:00 am and is filed under Campaign '20, Democrat Party. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.
You must be logged in to post a comment.

Shot in the Dark is a
WordPress joint.
Entries (RSS)
and Comments (RSS).
November 26th, 2019 at 6:33 am
Beto comes for our guns, Harris starts nationalizing private business.
And the Democrats cheer.
November 26th, 2019 at 6:41 am
There is a simple, non-coercive, easy to implement way to dramatically lower drug prices that fully embraces free market principles. Donald Trump could do it tomorrow morning with a stroke of his pen.
All he would have to do is order the FDA to approve any drug for sale in the United States that has been approved for sale in the EU and Canada.
Competitors would flow across the borders.
The FDA is not about safe drugs, it is about maintaining monopoly.
November 26th, 2019 at 7:48 am
There is such a thing as an institutional memory, passed on to each new generation. The FDA nearly approved thalidomide, following the lead of European agencies who had done so. The memory of how narrowly America dodged that bullet, lingers.
American lawyers have a much lower health risk tolerance for their clients than other nations. For any illness, there must be a deep pocket from which to draw compensation, even if that means changing the law retroactively. The attempts to hold firearms manufacturers liable for the misdeeds of criminals is a stark example. The federal government had to establish a National Vaccine Injury Compensation Program to insulate makers of certain vaccines from lawsuits, else there’d be nobody crazy enough to make the vaccines. Whether the federal government should extend that protection to other vaccines, manufactured in other countries, is a debatable point.